These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

315 related articles for article (PubMed ID: 33920461)

  • 1. Analytical Techniques for Structural Characterization of Proteins in Solid Pharmaceutical Forms: An Overview.
    Bolje A; Gobec S
    Pharmaceutics; 2021 Apr; 13(4):. PubMed ID: 33920461
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Instability of therapeutic proteins - An overview of stresses, stabilization mechanisms and analytical techniques involved in lyophilized proteins.
    Butreddy A; Janga KY; Ajjarapu S; Sarabu S; Dudhipala N
    Int J Biol Macromol; 2021 Jan; 167():309-325. PubMed ID: 33275971
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recent progress in drying technologies for improving the stability and delivery efficiency of biopharmaceuticals.
    Emami F; Keihan Shokooh M; Mostafavi Yazdi SJ
    J Pharm Investig; 2023; 53(1):35-57. PubMed ID: 36568503
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lyophilization and development of solid protein pharmaceuticals.
    Wang W
    Int J Pharm; 2000 Aug; 203(1-2):1-60. PubMed ID: 10967427
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of stable lyophilized protein drug products.
    Remmele RL; Krishnan S; Callahan WJ
    Curr Pharm Biotechnol; 2012 Mar; 13(3):471-96. PubMed ID: 22283723
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fundamentals of freeze-drying.
    Nail SL; Jiang S; Chongprasert S; Knopp SA
    Pharm Biotechnol; 2002; 14():281-360. PubMed ID: 12189727
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Arginine as an Excipient for Protein Freeze-Drying: A Mini Review.
    Stärtzel P
    J Pharm Sci; 2018 Apr; 107(4):960-967. PubMed ID: 29183741
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Physical characterization of pharmaceutical formulations in frozen and freeze-dried solid states: techniques and applications in freeze-drying development.
    Liu J
    Pharm Dev Technol; 2006 Feb; 11(1):3-28. PubMed ID: 16544906
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Freeze-Drying of L-Arginine/Sucrose-Based Protein Formulations, Part 2: Optimization of Formulation Design and Freeze-Drying Process Conditions for an L-Arginine Chloride-Based Protein Formulation System.
    Stärtzel P; Gieseler H; Gieseler M; Abdul-Fattah AM; Adler M; Mahler HC; Goldbach P
    J Pharm Sci; 2015 Dec; 104(12):4241-4256. PubMed ID: 26422647
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of drying method and excipient on structure and stability of protein solids using solid-state hydrogen/deuterium exchange mass spectrometry (ssHDX-MS).
    Wilson NE; Topp EM; Zhou QT
    Int J Pharm; 2019 Aug; 567():118470. PubMed ID: 31252148
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The impact of drying method and formulation on the physical properties and stability of methionyl human growth hormone in the amorphous solid state.
    Abdul-Fattah AM; Lechuga-Ballesteros D; Kalonia DS; Pikal MJ
    J Pharm Sci; 2008 Jan; 97(1):163-84. PubMed ID: 17722086
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Freeze drying of L-arginine/sucrose-based protein formulations, part I: influence of formulation and arginine counter ion on the critical formulation temperature, product performance and protein stability.
    Stärtzel P; Gieseler H; Gieseler M; Abdul-Fattah AM; Adler M; Mahler HC; Goldbach P
    J Pharm Sci; 2015 Jul; 104(7):2345-58. PubMed ID: 25994980
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lyophilization of Small-Molecule Injectables: an Industry Perspective on Formulation Development, Process Optimization, Scale-Up Challenges, and Drug Product Quality Attributes.
    Butreddy A; Dudhipala N; Janga KY; Gaddam RP
    AAPS PharmSciTech; 2020 Sep; 21(7):252. PubMed ID: 32885357
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Excipients in freeze-dried biopharmaceuticals: Contributions toward formulation stability and lyophilisation cycle optimisation.
    Bjelošević M; Zvonar Pobirk A; Planinšek O; Ahlin Grabnar P
    Int J Pharm; 2020 Feb; 576():119029. PubMed ID: 31953087
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of Protein-Excipient Microheterogeneity in Biopharmaceutical Solid-State Formulations by Confocal Fluorescence Microscopy.
    Koshari SH; Ross JL; Nayak PK; Zarraga IE; Rajagopal K; Wagner NJ; Lenhoff AM
    Mol Pharm; 2017 Feb; 14(2):546-553. PubMed ID: 28094996
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drying-induced variations in physico-chemical properties of amorphous pharmaceuticals and their impact on stability (I): stability of a monoclonal antibody.
    Abdul-Fattah AM; Truong-Le V; Yee L; Nguyen L; Kalonia DS; Cicerone MT; Pikal MJ
    J Pharm Sci; 2007 Aug; 96(8):1983-2008. PubMed ID: 17286290
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Conformational analysis of protein secondary structure during spray-drying of antibody/mannitol formulations.
    Schüle S; Friess W; Bechtold-Peters K; Garidel P
    Eur J Pharm Biopharm; 2007 Jan; 65(1):1-9. PubMed ID: 17034996
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Formulation and stability of cytokine therapeutics.
    Lipiäinen T; Peltoniemi M; Sarkhel S; Yrjönen T; Vuorela H; Urtti A; Juppo A
    J Pharm Sci; 2015 Feb; 104(2):307-26. PubMed ID: 25492409
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Principles of Freeze-Drying and Application of Analytical Technologies.
    Ward KR; Matejtschuk P
    Methods Mol Biol; 2021; 2180():99-127. PubMed ID: 32797409
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmaceutical protein solids: Drying technology, solid-state characterization and stability.
    Chen Y; Mutukuri TT; Wilson NE; Zhou QT
    Adv Drug Deliv Rev; 2021 May; 172():211-233. PubMed ID: 33705880
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.